title: Response.
authors.affiliation: Affiliations of authors: Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY (IGG); University of Texas MD Anderson Cancer Center, Houston, TX (MIH); Amgen Inc., Thousand Oaks, CA (RKJ). glezermi@mskcc.org.
authors.forename: Ilya G
authors.initials: IG
authors.lastname: Glezerman
authors.affiliation: Affiliations of authors: Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY (IGG); University of Texas MD Anderson Cancer Center, Houston, TX (MIH); Amgen Inc., Thousand Oaks, CA (RKJ).
authors.forename: Mimi I
authors.initials: MI
authors.lastname: Hu
authors.affiliation: Affiliations of authors: Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY (IGG); University of Texas MD Anderson Cancer Center, Houston, TX (MIH); Amgen Inc., Thousand Oaks, CA (RKJ).
authors.forename: Rajul K
authors.initials: RK
authors.lastname: Jain
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000150:complications*; D004164:Diphosphonates / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy* / Q000209:etiology*; D008297:Male
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D050071:Bone Density Conservation Agents; D004164:Diphosphonates